The update builds on Themis V2, a life-sized humanoid introduced in April 2025 that the company described as one of the most agile robots in its class. Westwood Robotics has unveiled Themis Gen 2.5, a ...

Seventy years ago, Lord Randolph Churchill delivered a stinging attack on the use of cloture to cut short debate in Britain’s Parliament. “The cloture is,” said he as quoted in a biography written by ...

1st May 2026: We added a new Tears of Themis code. Tears of Themis is a popular free-to-play visual novel from Genshin Impact makers HoYoverse. Blending dating sim and detective games, it mashes up ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas ...

For 3½ harrowing years, out of deference to an old ally, the U.S. has been playing along with the increasingly absurd legal fiction that revolt-torn Algeria is just another French province, like ...

Gujarat Themis Biosyn shares spiked 14.3 per cent in trade on BSE, logging an intra-day high at ₹369.4 per share. At 11:58 AM, Gujarat Themis Biosyn’s share price was trading 14.31 per cent higher at ...

Mumbai: Gujarat Themis Biosyn is making a decisive global push, betting on a high-value pharmaceutical portfolio to scale beyond its traditional base. The company has signed an agreement to acquire ...

Mumbai-based Gujarat Themis Biosyn Ltd. (GTBL) has informed exchanges that it has signed an asset purchase agreement with Sanofi to acquire a portfolio of anti-tuberculosis (TB) and anti-infective ...

Gujarat Themis Biosyn Ltd. will acquire a portfolio of anti-tuberculosis (TB) and anti-infective brands from Sanofi, the French-holding company of the Sanofi group. The company has entered into an ...